A telehealth psychiatry group recently asked our firm a simple question: "If the DEA finalizes its telemedicine prescribing rules tomorrow, are we ready?" The honest answer was no — not because the group was careless, but because it had spent three years building workflows around a "temporary" flexibility that kept getting renewed just long enough to feel permanent. That's the trap a lot of telehealth practices are in right now, and 2026 is the year to get out of it.

The Federal Picture: Another Extension, Not a Resolution

In January 2026, the DEA and HHS issued their fourth temporary extension of the COVID-era telemedicine flexibilities that allow practitioners to prescribe Schedule II–V controlled substances via telemedicine without first conducting an in-person evaluation. This latest extension runs through December 31, 2026, and also permits audio-only telehealth encounters for Schedule III–V narcotic medications used to treat opioid use disorder.

The agencies have been candid about why they keep extending rather than finalizing: they're still working through a large volume of public comment on a proposed permanent framework built around "special registrations" for telemedicine prescribers. That framework, first proposed in January 2025, would create structured pathways for telehealth practitioners to prescribe controlled substances and for online platforms to dispense them — but it would also come with new requirements around prescription drug monitoring checks, identity verification, credentialing, and recordkeeping.

The practical takeaway: nothing has changed in day-to-day prescribing authority for now, but "for now" has an expiration date, and it keeps moving. Four extensions in, the pattern is clear — regulators are buying time, not backing away from tighter rules. Practices that have built controlled-substance telehealth prescribing into their care model should treat 2026 as a planning year, not a reason to relax.

(Editor's note: the DEA/HHS extension referenced here runs through Dec. 31, 2026 — if this post runs after that date or after permanent rules are finalized, this section should be updated.)

The Florida Layer: Registration, Standards of Care, and Out-of-State Practitioners

Florida's own telehealth framework, codified in section 456.47 of the Florida Statutes, predates the federal pandemic flexibilities and remains the backbone of how telehealth is regulated in the state. A few points are worth reinforcing:

• Florida-licensed practitioners do not need a separate telehealth registration to treat patients located in Florida — the existing license covers it, provided the practitioner meets the same standard of care that applies to in-person treatment.
• Out-of-state practitioners treating Florida patients must register with the Florida Department of Health (or the applicable board) as an out-of-state telehealth provider. That registration requires an active, unencumbered license substantially similar to one of the license types enumerated in the statute, a designated in-state registered agent for service of process, and proof of liability coverage or financial responsibility.
• Out-of-state registrants may not open a Florida office or provide in-person care to Florida patients — the registration is telehealth-only, and stepping outside those bounds can jeopardize the registration and expose the practitioner to unlicensed-practice risk.
• The Department of Health is required to publish telehealth registrants' training and education history publicly, which makes accurate, complete applications more important than a routine licensing filing might otherwise warrant.

Don't Forget the Licensure Layer

Registration under § 456.47 solves the telehealth-specific piece, but it doesn't replace full licensure — and many multistate groups conflate the two. A physician who wants to treat Florida patients as if they were local (not just via the lighter-touch telehealth registration) still needs full Florida licensure or a pathway like the Interstate Medical Licensure Compact, which expedites licensing for physicians practicing across member states. Groups scaling into Florida should map out, patient by patient and state by state, which pathway actually applies — the fastest option is not always the right one for the scope of care being delivered.

Three Things to Do Now

1. Audit your controlled-substance telehealth prescribing workflows. Document how patient identity is verified, how PDMP checks are handled, and how records are retained. These are exactly the areas the proposed special registration framework is expected to formalize — building the habits now reduces the lift later.
2. Confirm registration status for every out-of-state practitioner treating Florida patients. Growth-stage telehealth companies frequently onboard providers faster than compliance teams can process registration paperwork. An unregistered out-of-state practitioner treating a Florida patient is an unlicensed-practice problem, not a paperwork technicality.
3. Build flexibility into vendor and technology contracts. Whatever the DEA's final rule requires — audio-video versus audio-only distinctions, new technology standards, additional recordkeeping — your EHR, e-prescribing, and telehealth platform vendors will need to accommodate it. Contracts signed now should anticipate a regulatory change is coming, not assume the status quo is permanent.

Frequently Asked Questions

Does a Florida-licensed physician need to register separately to provide telehealth? No. An existing Florida license covers telehealth services to Florida patients, provided the same standard of care applies as in-person treatment.

Can an out-of-state telehealth registrant open a satellite office in Florida? No. Out-of-state telehealth registration does not permit an in-person Florida office or in-person care — doing so risks the registration and creates unlicensed-practice exposure.

Will the DEA's controlled-substance telehealth flexibilities expire in 2026? The current extension runs through December 31, 2026. The DEA and HHS have signaled intent to replace it with a permanent "special registration" framework, though the final rule has not yet been issued.

The Bottom Line

Telehealth regulation in 2026 is defined by borrowed time. The federal government has made clear it intends to replace the current stopgap extensions with a permanent framework, and Florida's own statutory structure continues to demand careful attention to registration, licensure, and standard-of-care requirements regardless of what happens federally. Providers and telehealth businesses that use this year to tighten their compliance posture — rather than waiting for the next extension announcement — will be far better positioned when the rules finally settle.

Florida Healthcare Law Firm regularly advises physicians, telehealth platforms, and digital health companies on prescribing compliance, out-of-state registration, and telehealth business structuring. If your practice or platform needs a compliance checkup ahead of the next regulatory shift, reach out to our telehealth team for a consultation.

This post is for general informational purposes and does not constitute legal advice. Telehealth and controlled-substance prescribing regulations are changing rapidly at both the state and federal level; providers should consult with healthcare counsel before making changes to prescribing or registration practices.